tiprankstipranks
Amplia Therapeutics Ltd. (AU:ATX)
ASX:ATX
Australian Market
ATX
Amplia Therapeutics
RESEARCH TOOLSreports

Amplia Therapeutics (ATX) Stock News & Sentiment

23 Followers
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
Premium
Company Announcements
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
4d ago
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
Premium
Company Announcements
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
5d ago
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
Premium
Company Announcements
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
20d ago
Amplia requests ASX trading halt ahead of key clinical trial data
Premium
Company Announcements
Amplia requests ASX trading halt ahead of key clinical trial data
24d ago
Amplia Therapeutics Reappoints Experienced CFO to Support Biotech Growth
Premium
Company Announcements
Amplia Therapeutics Reappoints Experienced CFO to Support Biotech Growth
2M ago
Amplia Expands U.S. Footprint With New Sites for Pancreatic Cancer Trial
Premium
Company Announcements
Amplia Expands U.S. Footprint With New Sites for Pancreatic Cancer Trial
2M ago
Amplia Secures Phase 3-Ready Supply with First Large-Scale Narmafotinib Manufacture
Premium
Company Announcements
Amplia Secures Phase 3-Ready Supply with First Large-Scale Narmafotinib Manufacture
3M ago
More AU:ATX News >

ATX News on the Web

Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
TipRanks News
Bullish
Biocurious: Battered local biotech valuations provide golden opportunities
StockHead
Neutral
Health Check: We will duck Donald’s tariffs, say CSL and Mayne Pharma
StockHead
Bearish
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
TipRanks News
Bullish
ASX Monthly Winners: Middle East war trips market in March, but winners emerged from the rubble
StockHead
Bullish
Health Check: The biotech winners and losers from a messy March of mayhem
StockHead
Neutral
Companies Like Amplia Therapeutics (ASX:ATX) Are In A Position To Invest In Growth
Simply Wall St
Neutral
Scott Power: ASX healthcare breaks losing streak in good news week
StockHead
Neutral

News Score - Last 7 Days

Neutral
AU:ATX
Sector Average
Media Buzz
This Week4 articles
Weekly Average4.75 articles
News Sentiment
This Week67%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:ATX’s Media Buzz Sentiment?
4 articles about AU:ATX were published this week. In an average week, 4.75 articles are published.
    What is AU:ATX’s weekly average amount of articles?
    In an average week, 4.75 articles about AU:ATX are published.
      What is AU:ATX’s News Sentiment?
      67% of articles about AU:ATX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week